Steven A. Sussman

A Fungal Immunotherapeutic Vaccine (NDV-3A) for Treatment of Recurrent Vulvovaginal Candidiasis—A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial

John E. Edwards, Michael M. Schwartz, Clint S. Schmidt et al. · Clinical Infectious Diseases · 2018 · 205 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

Ibrexafungerp Versus Placebo for Vulvovaginal Candidiasis Treatment: A Phase 3, Randomized, Controlled Superiority Trial (VANISH 303)

Jane R. Schwebke, Ryan Sobel, Janet Gersten et al. · Clinical Infectious Diseases · 2021 · 76 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Efficacy and safety of ospemifene in postmenopausal women with moderate-to-severe vaginal dryness: a phase 3, randomized, double-blind, placebo-controlled, multicenter trial

David F. Archer, Steven R. Goldstein, James A. Simon et al. · Menopause The Journal of The North American Menopause Society · 2019 · 65 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

A real-world comparison of the clinical and economic utility of OVA1 and CA125 in assessing ovarian tumor malignancy risk

Gerard Reilly, David A. Gregory, Dennis J. Scotti et al. · Journal of Comparative Effectiveness Research · 2023 · 11 citations · Full text

Medicine, Gynecology, Oncology +17